Citrine Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Citrine Capital's ABBV Position: Q3 2026 in Review
Citrine Capital increased its AbbVie (ABBV) stake by 2.8% in Q3 2026, buying an estimated $7.69K and bringing the position to 1,105 shares worth $289K. The position accounts for 0.1% of the portfolio, ranked #48.
Citrine Capital first reported a position in ABBV in Q1 2026 and has held it in 3 quarters since. 4,278 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Citrine Capital held 1,105 shares of AbbVie worth $289K as of Q3 2026.
- Citrine Capital bought 30 AbbVie shares in Q3 2026, an estimated $7.69K.
- AbbVie made up 0.1% of Citrine Capital's portfolio in Q3 2026, its #48 holding.
- Citrine Capital first reported a position in AbbVie in Q1 2026 and has held it in 3 quarters since.
- 4,278 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Citrine Capital's 13F filing for Q3 2026, filed 14 Oct 2026.